Acipimox in primary hyperlipidemias: safety and efficacy evaluated in six months Acipimox en hiperlipidemias primarias: seguridad y eficacia evaluada a 6 meses.
1991
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI